Therefore, MGEL20154, also a potent activator of pparα, could inhibit NPC1L1 expression in Caco-2 cells, suggesting that it can suppress cholesterol absorption into cells from the digestive tract and result in an anti-obesity effect. Here, NPC1L1 is linked to obesity disorder.